Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
David Schaffer ā Member Board Of Directors at uniQure
Executive Bio
David Schaffer serves as the Member Board Of Directors of uniQure. David started at uniQure in January of 2014. David currently resides in San Francisco Bay Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably